Evidence map›Paper›PMID 42882835›Full record

ReviewCancers2026

Allele-Stratified Activity of RAS Inhibitors in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Exploratory Meta-Analysis.

Munahil Ilyas Muhammad, Aisha Al-Khinji, Mayasa Al-Ansari, Najlaa Al-Marri, Shahad Al-Shaheen, Dhafer Malouche

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Munahil Ilyas MuhammadCollege of Medicine, Qatar University, Doha P.O. Box 2713, Qatar.ORCID 0009-0000-1221-9921
Aisha Al-KhinjiCollege of Medicine, Qatar University, Doha P.O. Box 2713, Qatar.ORCID 0000-0002-5253-1845
Mayasa Al-AnsariCollege of Medicine, Qatar University, Doha P.O. Box 2713, Qatar.ORCID 0009-0001-8088-6408
Najlaa Al-MarriCollege of Medicine, Qatar University, Doha P.O. Box 2713, Qatar.ORCID 0009-0001-8028-6840
Shahad Al-ShaheenCollege of Medicine, Qatar University, Doha P.O. Box 2713, Qatar.ORCID 0009-0005-9179-7979
Dhafer MaloucheDepartment of Mathematics and Statistics, College of Arts and Sciences, Qatar University, Doha P.O. Box 2713, Qatar.ORCID 0000-0002-0494-7141

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

allele-specific therapyevidence stratificationKRAS mutationsPDACprecision oncologypreclinical model validityRAS inhibitors

Identifiers

PMID42882835
PMCPMC13664068

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.